Live intelligence

Latest AI updates

2 updates
Industry

Isomorphic Labs Secures $2.1 Billion to Advance AI-Driven Drug Discovery

Isomorphic Labs, the London-based AI drug discovery company spun out of Google DeepMind in 2021, has successfully closed a US$2.1 billion funding round. The investment was led by Thrive Capital, with participation from its parent company Alphabet, as<!--autointro-->

AlphabetDeepMindAI drug discovery
Industry

Isomorphic Labs Nears $2 Billion Funding Round to Accelerate AI-Powered Drug Discovery

London, UK&nbsp;– Isomorphic Labs, the pioneering AI-driven drug discovery company spun out of Google DeepMind in 2021, is in advanced negotiations to secure over $2 billion in a new funding round. The investment is being led by Thrive Capital, with <!--autointro-->

Isomorphic LabsAI drug discoveryThrive Capital